Atlas Trials

pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer

Clinical trial NCT07115927 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07115927
Sponsor
University College, London
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2025-09-30
Primary completion
2030-04-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.